LC-MS identifies oncogene Rab33B in ischemic brain tissue
Up-regulation of the oncogene Rab33B is detected in ischemic brain tissue using LC-MS

HPLC, UHPLC

LC-MS identifies oncogene Rab33B in ischemic brain tissue

26 Nov, 2010

Published over 15 years ago. See the latest and most current information on HPLC, UHPLC.

Research conducted using liquid chromatography-mass spectrometry (LC-MS) has detected higher levels of the oncogene Rab33B in brain tissue following an ischemic cerebral event.

Ischemia occurs when oxygen is unable to reach the tissue in the brain and is the most common cause of stroke.

Typically, it is caused by the blockage of a vessel elsewhere in the body, unlike haemorrhagic stroke which occurs when weakened vessels within the brain itself bleed into the tissue.

A study published in Experimental & Translational Stroke Medicine reports the findings of LC-MS research into the after-effects of ischemic attack.

Specifically, the scientists focused on levels of Rab33B, a known oncogene which, if expressed to a significantly high degree, can be associated with the formation of tumours.

They found a time-dependent link between ischemia in the brain and the number of cells found to be positive for content of Rab33B, with a general up-regulation of the oncogene throughout the ischemic striatum.

Latest News

Explore Our Other Sites

Labmate Online
Physics-based machine learning sharpens images taken through through fog, tissue, cloudy liquids
Explore more Arrow
Envirotech Online
East Asia expands cooperative POPs monitoring with greater focus on PFAS analysis
Explore more Arrow
Pollution Solutions Online
Leading UK biogas operator places first orders for new FlowSep technology
Explore more Arrow
Petro Online
Beyond standard cetane testing: Unlocking research for the next generation of sustainable fuels
Explore more Arrow